IMMURON LIMITED - AMERICAN DEPOSITARY SHARES
IMMURON LIMITED - AMERICAN DEPOSITARY SHARES
Hinterlegungsschein · US45254U1016 · IMRN · A2DTD8 (XNAS)
Übersicht
1,68 USD
-4,01 % -0,07 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
13.06.2025 22:04

Aktuelle Kurse von IMMURON LIMITED - AMERICAN DEPOSITARY SHARES

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
IMRN
USD
13.06.2025 22:04
1,68 USD
1,75 USD
-4,01 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -1,18 % -11,58 % -7,69 % -20,95 % -22,58 % -80,42 %

Firmenprofil zu IMMURON LIMITED - AMERICAN DEPOSITARY SHARES Hinterlegungsschein

Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for dietary supplement for digestive tract protection; and Protectyn, an immune supplement to maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III clinical trials to reduce the risk of contracting travelers' diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in clinical development stage focuses on treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and ETEC infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is based in Carlton, Australia.

Unternehmensdaten

Name IMMURON LIMITED - AMERICAN DEPOSITARY SHARES
Firma Immuron Limited
Symbol IMRN
Website https://www.immuron.com.au
Heimatbörse XNAS NASDAQ
WKN A2DTD8
ISIN US45254U1016
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Biotechnology
CEO Mr. Steven George Lydeamore CPA, M.B.A.
Marktkapitalisierung 11 Mio
Land Australien
Währung USD
Mitarbeiter 0,0 T
Adresse 25-37 Chapman Street, 3130 Carlton
IPO Datum 2017-06-09

Ticker Symbole

Name Symbol
Frankfurt ANWA.F
NASDAQ IMRN

Weitere Aktien

Investoren die IMMURON LIMITED - AMERICAN DEPOSITARY SHARES die halten, haben auch folgende Aktien im Depot:
ENCRES DUBUIT  EO-,40
ENCRES DUBUIT EO-,40 Aktie
VALEO SA 17-22 MTN
VALEO SA 17-22 MTN Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025